Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy (PLACENTA3D)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00930397|
Recruitment Status : Completed
First Posted : June 30, 2009
Last Update Posted : May 27, 2013
|Condition or disease|
|Pre-eclampsia Intra-uterine Growth Restriction Placental Insufficiency 3D Doppler Ultrasound.|
|Study Type :||Observational|
|Actual Enrollment :||146 participants|
|Official Title:||The Evaluation of UTERO - Placental 3D Doppler Examination Potential Interest for Pre- Eclampsia Screening During Pregnancy. Observational Study in 100 Women at High Risk for Pre- Eclampsia and 70 Low Risk Women.|
|Study Start Date :||July 2009|
|Actual Primary Completion Date :||November 2011|
|Actual Study Completion Date :||November 2011|
Low risk women
Women without any personal risk.
High risk women
Women at high risk for pre-eclampsia with personal of pre-eclampsia and/or IUGR in a previous pregnancy, diabetes, auto-immune syndrome such as lupus, hypertension, renal insufficiency and anti-phospholipid.
- Existence of pre eclampsia and/or IUGR [ Time Frame: at the end of the pregnancy ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00930397
|Hôpital LARIBOISIERE Service de gynécologie- obstétrique|
|Paris, France, 75010|
|Principal Investigator:||Olivier MOREL, MD||Assistance Publique - Hôpitaux de Paris|